4.7 Article

Incorporation of a Ligand Peptide for Immune Inhibitory Receptor LAIR-1 on Biomaterial Surfaces Inhibits Macrophage Inflammatory Responses

Journal

ADVANCED HEALTHCARE MATERIALS
Volume 6, Issue 24, Pages -

Publisher

WILEY
DOI: 10.1002/adhm.201700707

Keywords

collagen peptides; immunomodulatory biomaterials; inflammation; LAIR-1; macrophages

Funding

  1. UC Irvine (award from the Henry Samueli School of Engineering Interdisciplinary Innovation Initiative)
  2. UC Irvine (award from the Council on Research, Computing and Libraries)
  3. UC Irvine (award from the Ayala School of Biological Sciences)
  4. National Institute of Health [DP2DE023319, R21EB022240]

Ask authors/readers for more resources

Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is an inhibitory receptor broadly expressed on immune cells, with its ligands residing within the extracellular matrix protein collagen. In this study, surfaces are modified with a LAIR-1 ligand peptide (LP), and it is observed that macrophages cultured on LAIR-1 LP-conjugated surfaces exhibit significantly reduced secretion of inflammatory cytokines in response to proinflammatory stimuli that reflect an injured environment. These downregulated mediators include TNF-alpha, MIP-1 alpha, MIP-1 beta, MIP-2, RANTES, and MIG. Knockdown of LAIR-1 using siRNA abrogates this inhibition of cytokine secretion, supporting the specificity of the inhibitory effect to this receptor. These results are the first to demonstrate that integration of LAIR-1 ligands with biomaterials could suppress inflammatory responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available